Thrilled to join the team at Sonic Incytes and help create accessible and affordable healthtech solutions – with health insights you can count on – to improve patient care.Recognizing the rise of chronic liver disease, Sonic Incytes is on a mission to make liver health a new vital sign. Its novel, point of care ultrasound solution, Velacur, is redefining the standard of care in quantifying liver tissue stiffness and attenuation to aid in the clinical management of patients with chronic liver disease.Founded in 2017, Sonic Incytes is a health technology company headquartered in Vancouver, British Columbia, Canada.

Creative Destruction Lab is a national program for massively scalable technology-based ventures. The BioMedTech stream supports creative, intelligent, and ambitious individuals and teams with strong backgrounds in chemical, biological, medical, materials, mechanical, electrical, and computer engineering.

Zolo is Canada's largest high tech real estate company.The Company, founded in 2012 now has approximately 1000 real estate sales representatives and mortgage brokers with offices serving consumers across Canada. Zolo.ca is Canada's largest broker-owned online real estate portal with over 15 million monthly visitors. Combining the best Agents and the best technology, we are changing the way Canadian's buy and sell their homes. ZOLO.CA - A BETTER WAY TO BUY, SELL AND FINANCE YOUR HOME

PureWeb Inc. Formerly Calgary Scientific Inc. PureWeb’s patented smart streaming technology enables anyone to publish, collaborate and interact with graphics rich files, including photo-real 3D simulations and gaming engine projects. We deploy on any cloud or hardware device without coding, moving or copying the source data. Our smart streaming technology is scalable and efficient, providing superior access while protecting the security of your data.Our award-winning ResolutionMD, is a mobile and web enterprise viewer that lets healthcare professionals collaborate while securely viewing 2D and 3D images, and clinically diagnose patients anywhere. ResolutionMD in partnership with leading medical imaging companies is installed in over 2500 healthcare facilities and 500,000 users worldwide.Our products also include real time interactive cloud deployment of 2D and 3D CAD and training simulators, 3D photo realistic automotive configurators, no download gaming, and Spaces for critical collaboration.

Led sale of the majority of the Company’s assets to HEGLN (Dalian) Pharmaceuticals, a PRC based corporation.Built the Company to commercialize breakthrough technology for the non-invasive diagnosis of medical conditions in urology and trauma. Responsible for in-licensing technology, team building, intellectual property management, corporate finance and product and business development. The Company’s first commercial product was distributed on a world wide basis by Laborie Medical and MMS Medical Instrumentation. In addition, the Company had collaborative agreements for product development with several multi-national medical device companies. Urodynamix Technologies Ltd remains a publicly traded company on the TSX Venture (URO:TSX.V

Creator, Founder and leader of the BC Excels program a rigorous one-year business development mentorship program for emerging companies seeking to enhance their management team, product plan, commercialization and intellectual property protection strategies. Including learning modules and hands on sessions, the member companies worked closely with BC Excels Mentors to develop and build their company. Now in its sixth year the program is sponsored by industry, government and professional organizations throughout British Columbia.The Program is now managed by Life Sciences BC.

Member of the Life Sciences Team and Investment Committee for Ventures West, an active venture capital investor in early stage life sciences and technology companies throughout North America with approximately $1 billion under management. Two major areas of responsibility included membership on the investment committee actively involved in review and investment, and providing strategic planning and input to Ventures West, limited partners and portfolio companies as an experienced entrepreneur and operator.

Reporting to the Chairman of the Board for all aspects of emerging medical device company focused on non-invasive patient monitoring and functional brain imaging.including strategic planning, corporate finance, mergers and acquisition. As CEO, grew VSM from 2 employees to almost 200 and evolved from an R&D company to a world class manufacturer and marketer of high tech medical products. The Company grew from zero revenue to sales of approximately $20mm in 2003.Successfully raised in excess of $65mm in capital and led the Company’s migration from the CDNX Venture to the TSE (TSX) with a corresponding increase in market capitalization from $2mm to $400mm in 2003. In 2003 VSM was voted the “BC Technology Industry Association / KPMG Emerging Company of the Year”, was featured in the 2003 Toronto Stock Exchange Annual Report and received the Industry Canada Export Award.